Our second major finding was that, in the A − T− stage, nonspecific AD markers, i.e., plasma GFAP and NfL, were significantly elevated in SVCI compared to CU, and remained relatively stable across all AT stages within the SVCI group. The gene discussed is GFAP; the disease is Alzheimer disease.